West Paces Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-27	Closed	-$17.1K	–	482
2025 Q1	$17.1K	Hold	27	–	–	﹤0.01%	307
2024 Q4	$19.2K	Hold	27	–	–	﹤0.01%	306
2024 Q3	$28.4K	Hold	27	–	–	0.01%	280
2024 Q2	$28.4K	Hold	27	–	–	0.01%	268
2024 Q1	$26K	Buy	27 +23	+575%	+$21.9K	0.01%	287
2023 Q4	$3.51K	Buy	4 +2	+100%	+$1.65K	﹤0.01%	432
2023 Q3	$1.65K	Hold	2	–	–	﹤0.01%	436
2023 Q2	$1.44K	Sell	2 -1	-33%	-$771	﹤0.01%	468
2023 Q1	$2.46K	Buy	3 +1	+50%	+$754	﹤0.01%	457
2022 Q4	$1.44K	Hold	2	–	–	﹤0.01%	455
2022 Q3	$1.38K	Buy	+2	New	+$1.26K	﹤0.01%	452
2022 Q2	–	Sell	-2	Closed	-$1.4K	–	603
2022 Q1	$1.4K	Buy	+2	New	+$1.26K	﹤0.01%	507
2021 Q2	–	Sell	-40	Closed	-$18.9K	–	626
2021 Q1	$18.9K	Buy	+40	New	+$19.5K	0.01%	271
2017 Q1	–	Sell	-22	Closed	-$8.08K	–	537
2016 Q4	$8.08K	Buy	+22	New	+$8.37K	0.01%	360